MAZE - CIK 0001842295
Maze Therapeutics, Inc. (MAZE) reported net income of -$131.12M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$131.12M | -351.0% |
| FY 2024 | $52.23M | - |
Maze Therapeutics, Inc. (MAZE) reported net income of -$131.12M for fiscal year 2025, as filed in its audited annual report with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.